SHELTON, Conn., April 25, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (NASDAQ: INTS), ("Intensity" or the "Company") a late-stage clinical biotechnology company focused on the discovery and ...
Intensity Therapeutics Inc (NASDAQ:INTS) shares are trading lower by 30.3% to 62 cents during Friday’s session after the company announced the pricing of a public offering expected to raise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results